Valuation: Olympus Corporation

Market Cap 2,024B 12.84B 11.1B 10.37B 9.51B 17.89B 1,222B 18.18B 122B 47.75B 612B 48.21B 47.15B P/E 2027 *
20.7x
P/E 2028 * 17.2x
Enterprise Value 2,109B 13.37B 11.57B 10.8B 9.91B 18.64B 1,273B 18.94B 127B 49.75B 638B 50.22B 49.12B EV / Sales 2027 *
1.97x
EV / Sales 2028 * 1.9x
Free-Float
94.53%
Yield 2027 *
1.62%
Yield 2028 * 1.69%
1 day+1.82%
1 week+4.73%
Current month+4.73%
1 month+7.68%
3 months+21.29%
6 months+1.09%
Current year-3.96%
1 week 1,761
Extreme 1761
1,920.5
1 month 1,703
Extreme 1703
1,920.5
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%+4.73%+4.47%-17.36% 12.84B
+2.41%+3.43%+28.93%+6.88% 220B
+2.39%+5.02%+2.09%-20.96% 144B
+1.36%+7.21%-19.42%+25.07% 134B
+0.02%+5.52%-52.19%-2.51% 71.46B
+0.45%+4.24%+14.51%+14.16% 51.71B
+1.05%+7.19%-14.90%-17.93% 50.84B
+3.28%+5.49%+27.35%+13.73% 41.23B
+1.79%+7.83%+44.69%+37.11% 39.95B
+2.08%+5.51%-0.32%-2.92% 32.42B
Average +1.66%+5.47%+3.52%+3.53% 79.78B
Weighted average by Cap. +1.79%+5.17%+4.11%+4.04%

Financials

2027 *2028 *
Net sales 1,071B 6.79B 5.87B 5.48B 5.03B 9.46B 646B 9.61B 64.34B 25.25B 324B 25.49B 24.93B 1,111B 7.04B 6.09B 5.69B 5.22B 9.82B 670B 9.97B 66.75B 26.2B 336B 26.45B 25.87B
Net income 99.38B 630M 545M 509M 467M 878M 59.97B 892M 5.97B 2.34B 30.06B 2.37B 2.31B 118B 751M 650M 607M 557M 1.05B 71.5B 1.06B 7.12B 2.79B 35.84B 2.82B 2.76B
Net Debt 84.71B 537M 465M 434M 398M 749M 51.12B 761M 5.09B 2B 25.62B 2.02B 1.97B 80.71B 512M 443M 413M 379M 713M 48.71B 725M 4.85B 1.9B 24.41B 1.92B 1.88B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-08-07 ¥1,906.00 +1.82% 6,114,900
26-08-06 ¥1,872.00 +3.60% 4,199,600
26-08-05 ¥1,807.00 -0.39% 2,945,200
26-08-04 ¥1,814.00 -0.27% 2,845,400
26-08-03 ¥1,819.00 -0.05% 4,210,500
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,906.00JPY
Average target price
1,951.54JPY
Spread / Average Target
+2.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock